Your symptoms made sense. We treat what they were managing.
If tianeptine use is part of what you’re carrying, we start with mental health and trauma. Healing begins in our Partial Hospitalization Program: a focused day of care, and home every night.
You deserve clear information and a conversation that leaves room for your needs, responsibilities, and choices.
These are rooms at our Denver office. You spend the day here, and you go home at night.
tianeptine and use treatment guidance for women in Denver is grounded in the FDA's stated approval information. Tianeptine is a drug, and the FDA has not approved it for any medical use in the United States. Publicly listed local information can be reviewed on the Denver location page.
Supporting guidance: Tianeptine Products Linked to Serious Harm, Overdoses, Death | FDA
Tianeptine and use treatment guidance for women in Denver begins with a key fact: tianeptine acts through opioid pathways and is not FDA-approved for any medical use in the United States. You can also explore kratom and emerging products guidance and focused kratom guidance for women.
What matters clinically is that tianeptine has opioid activity and may be present in products marketed as supplements or cognitive enhancers. Product contents and combined ingredients may be uncertain. Care should focus on what you took, patterns over time, effects, withdrawal experiences, other substances, and any changes in your health or daily functioning.
Extreme sleepiness, slowed or difficult breathing, inability to wake, or bluish lips or fingertips requires emergency help now. Beyond an immediate crisis, appropriate care can assess physical dependence, loss of control, and consequences separately. That distinction supports a more useful recommendation while preserving your ability to make informed choices about treatment.
There is no dependable onset time that can safely predict your experience, especially when products may contain uncertain or blended ingredients. Instead of using timing to judge safety, consider how use is affecting you. Outpatient treatment guidance and Intensive Outpatient Program guidance explain possible care structures.
A simple strength comparison with morphine cannot determine your risk or level of care. Effects depend on the actual product, other ingredients, patterns of use, and your health. Review Partial Hospitalization Program guidance alongside outpatient treatment guidance to understand differing levels of structure.
Trying to rank one substance against another can hide the information that matters most for you. Clinicians need to understand whether you are experiencing withdrawal, sedation, escalating use, persistent urges, difficulty stopping, or harm to health and daily life. They also consider whether more than one substance is involved. Tianeptine may be used with kratom, kava, gabapentin, phenibut, racetams, or other products, which makes a single comparison even less useful.
Level-of-care decisions are not based on a potency label alone. Outpatient care generally represents less structure, while an Intensive Outpatient Program (IOP) or Partial Hospitalization Program (PHP) represents progressively more scheduled support. Education can help you recognize these broad differences. Only an individual assessment can connect them to your withdrawal risk, physical and emotional health, stability, support, and ability to participate safely while managing responsibilities outside care.
women’s treatment programs may involve appointments followed by a return home the same day. You can also review admissions information when deciding whether a conversation about outpatient care feels helpful.
Explore care at our Denver location and communities we serve for related guidance. Call admissions when you want to discuss your own situation.
Call AdmissionsDependence means your body has adapted and stopping may bring withdrawal symptoms. Addiction involves continued use despite harm, often with impaired control or strong urges. They can overlap, but they are not identical. A careful assessment can consider both without reducing you to a label.
Frequent use, difficulty cutting back, withdrawal symptoms, growing preoccupation, or continued use despite problems deserve attention. Changes in sleep, mood, finances, relationships, work, or caregiving can also matter. You do not need to decide whether your experience qualifies as addiction before seeking a thoughtful assessment.
An assessment may explore what product you use, how often use occurs, other substances or medications, withdrawal experiences, physical and emotional health, safety concerns, and daily responsibilities. These details help a clinician recommend an appropriate level of care rather than relying on one symptom or label.
Women’s Recovery's public contact page lists 3801 E Florida Ave, Ste 650, Denver, CO 80210 as its Denver location and publishes 833.754.0554 as the contact number. This information verifies only that public address and telephone number. It does not independently establish licensing, accreditation, treatment availability, eligibility, schedules, outcomes, or details about another facility.
The City and County of Denver publishes substance-use support links, harm-reduction resources, treatment-navigation links, and crisis directions for Denver residents. These public materials provide resource navigation only. They are not Women’s Recovery treatment, a promise that any service is available, individualized medical guidance, or evidence of endorsement, partnership, or affiliation with Women’s Recovery.
Read how we select health information sources and apply the Women’s Recovery editorial policy. These references provide general education and context; they do not establish an individual diagnosis, service, or treatment recommendation.
If you can't believe that yet, borrow my hope. Just long enough to find your own.
Women’s Recovery graduate
